Two studies published in JAMA Oncology examined the use of chatbots in providing cancer-related advice and treatment strategies. The first study found that while most of the chatbot’s answers were in line with guidelines from the National Comprehensive Cancer Network (NCCN), one-third of the responses were not fully concordant. The researchers suggested that patients should be informed that these chatbots are not a reliable source of treatment information.
The second study showed that AI chatbots generally provided accurate information on cancer-related search queries, but the responses were not easily actionable and were written at a college level. The researchers concluded that AI chatbots can serve as a supplementary resource for medical information but should not replace healthcare professionals for personalized healthcare questions. An editorial accompanying the studies emphasized the need for careful evaluation of these technologies and their potential to improve cancer care for patients who may not have access to high-quality care.
The whytry.ai article you just read is a brief synopsis; the original article can be found here: Read the Full Article…
